2024-2029 UK Respiratory Diseases Diagnostic Market for Adenovirus, Coronavirus, Enterovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Rhinovirus, and Tuberculosis Tests: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
About This ReportThis new report from LeadingMarketResearch.com presents detailed analysis of the UK Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. ;In addition to market share and sales forecasts, the report:- Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;- Reviews features and operating characteristics of major analyzers used for microbiology testing; - Profiles key suppliers and potential market entrants developing innovative technologies and products; and - Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.MethodologyThe report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearch's proprietary data files was conducted.
Introduction
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. ADENOVIRUS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
2. CORONAVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. INFLUENZA VIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. LEGIONELLA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. MONONUCLEOSIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. MYCOPLASMA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
7. PNEUMONIA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. RESPIRATORY SYNCYTIAL VIRUS (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. TUBERCULOSIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Table of Contents (continued)
B. Instrumentation Review of Leading Analyzers Marketed
by Abbott, Beckman Coulter/Danaher, BioMerieux,
Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,
Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. MOLECULAR DIAGNOSTICS
2. MONOCLONAL ANTIBODIES
3. IMMUNOASSAYS
4. DIFFERENTIAL LIGHT SCATTERING
5. INFORMATION TECHNOLOGY
6. ARTIFICIAL INTELLIGENCE
7. LIPOSOMES
8. FLOW CYTOMETRY
9. CHROMATOGRAPHY
10. DIAGNOSTIC IMAGING
11. GEL MICRODROPLETS
12. OTHER
III. Country Analysis: Market Size, Growth and Major
Suppliers’ Sales and Market Shares
Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Information Technology
D. Auxiliary Products
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
Table of Contents (continued)
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
GSK Biologicals
Hologic
Leica Biosystems
Lonza
Ortho-Clinical Diagnostics
PerkinElmer
Qiagen
Roche
Scienion
Sequenom
SeraCare
Table of Contents (continued)
Siemens Healthineers
Takara Bio
Thermo Fisher
Wako
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. ADENOVIRUS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
2. CORONAVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. INFLUENZA VIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. LEGIONELLA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. MONONUCLEOSIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. MYCOPLASMA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
7. PNEUMONIA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. RESPIRATORY SYNCYTIAL VIRUS (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. TUBERCULOSIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Table of Contents (continued)
B. Instrumentation Review of Leading Analyzers Marketed
by Abbott, Beckman Coulter/Danaher, BioMerieux,
Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,
Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. MOLECULAR DIAGNOSTICS
2. MONOCLONAL ANTIBODIES
3. IMMUNOASSAYS
4. DIFFERENTIAL LIGHT SCATTERING
5. INFORMATION TECHNOLOGY
6. ARTIFICIAL INTELLIGENCE
7. LIPOSOMES
8. FLOW CYTOMETRY
9. CHROMATOGRAPHY
10. DIAGNOSTIC IMAGING
11. GEL MICRODROPLETS
12. OTHER
III. Country Analysis: Market Size, Growth and Major
Suppliers’ Sales and Market Shares
Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Information Technology
D. Auxiliary Products
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
Table of Contents (continued)
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
GSK Biologicals
Hologic
Leica Biosystems
Lonza
Ortho-Clinical Diagnostics
PerkinElmer
Qiagen
Roche
Scienion
Sequenom
SeraCare
Table of Contents (continued)
Siemens Healthineers
Takara Bio
Thermo Fisher
Wako